Recent Posts
Archives
IR Department Managing Director: Award Finalist

Podcast - interview with Peter Devine, CEO of Uniseed

Podcast - IR Department talks to Race Oncology's CSO Dr Daniel Tillett

Our Digital Content Producer, Paul Langley, talks with Race Oncology's CSO Dr Daniel Tillett, who explains how the recent clinical trials are evolving and what it means for the future. He gives a brief overview on the history of Race, their aspirations and milestones for development and eventual commercialisation of Zantrene.
Podcast - IR Department talks with AdAlta CEO & MD, Dr Tim Oldham

Our Communications Director, Cherie Hartley, talks with AdAlta's CEO & M.D. Dr Tim Oldham at this year's Bioshares Biotech Summit, who takes us inside the mind of a biotech company. He discussed the importance of focus for a platform company, explains why making decisions on a day-to-day basis is so crucial for risk reduction and why they're investing in supporting core strategies as well as their target product profile.
IRD Invest March 2022 - Openpay

IRD Invest March 2022 - "Project: 2025"
Watch the replay of Openpay's CEO (Australia & New Zealand) Dion Appel.
IRD Invest March 2022 - Oventus

IRD Invest 31st March 2022 - "Project: 2025"
Watch the replay of Oventus CEO John Cox's presentation.
IRD Invest March 2022 - Pureprofile

IRD Invest 31st March 2022 - "Project: 2025"
Watch the replay of Pureprofile CEO Martin Filz's presentation.
Interview with Ben Fogarty, CEO (UK) XPON

We speak to Ben Fogarty, CEO (UK & Europe) from XPON Technologies Group (see video below) about what the future holds for them and the impact of the upcoming ‘Metaverse’.
A groundbreaking approach to cancer treatment

A number of breakthrough discoveries for Race Oncology's (ASX:RAC) drug Zantrene® over the past 18 months has seen the company evolve its strategy and clinical programs in order to maximise these opportunities. What does the future for Race look like?
Island Pharmaceuticals discuss the Dengue Fever pandemic

Dengue fever is a massive pandemic that continues to spread beyond geographical limits, with 400 million people affected each year. Island Pharmaceuticals (ASX: ILA) is at the forefront of the battle. Here, CEO David Foster talks about the issue:
IR Department celebrates International Women's Day 2022

Today is International Women’s Day #IWD2022 – a day that shines a spotlight on how we can strive for a world that’s more diverse, equitable and inclusive. It’s a day that recognises the achievements of women, and a world where difference is valued and celebrated!
In recognition of the day, we spoke to some of the inspiring women we work with and invited them to share their views on how we can all take action for a gender equal world in order to #BreakTheBias.
You can find out more about International Women’s Day by visiting https://www.internationalwomensday.com
The evolution of social media in crisis communications - Part Two: When the crisis hits

Following on from where I left off in Part One of this blog, which looked at the evolution of social media in crisis management and five key steps to prepare your company before a crisis hits, today’s blog deals with strategies to help mitigate damage once an issue has hit.
ASEAN Dengue Day: Island Pharmaceuticals Investor briefing video

CEO and Managing Director at Island Pharmaceuticals Dr David Foster, Executive Chairman Dr Paul MacLeman, and Infectious Disease expert Prof Stephen Thomas MD discuss the most current understanding of the impact of dengue fever on the global community, the pace of growth in the ASEAN region and the changing battle against dengue in light of climate change and COVID-19.
Are you ready for the 2022 Financial Year? What you need to know and trends to watch out for.

End of Financial Year is a great time for investors to take stock and plan for the coming 12 months.
IR Department Account Director Juliana Roadley speaks to Morgans Reynolds Securities Private Client Adviser Patricia Tsicalas about the year that was 2021, as well as what to expect and how to prepare for the year ahead – covering one of the hottest topics going at the moment, the Australian Government’s upcoming changes to superannuation.
Three takeaways from the 2021 AIRA conference

The Australasian Investor Relations Association's (AIRA) annual conference is a great place to hear new ideas, exchange views, and reconnect with colleagues.
IR Department's Account Director, Juliana Roadley, attended this year’s conference in person. Here are her three clear takeaways:
Earned vs Bought media: Is it worth paying for a headline?

A media landscape dominated by digital is characterised by a lot of space, a lot of noise, and a lot of competition for air time. It’s tempting to consider paying for a headline… but is the cost worth it? We share our experience.
No-Nonsense Guide to Building a Social Media Strategy

We came across this insightful piece by IRM that covers the social media strategy must haves.
The "No-Nonsense Guide to Building a Social Media Strategy" covers defining your social media goals and it's audience and how to engage so your strategy is doing more than just making noise.
International Women's Day 2021 #GenerationEquality

March 8th is International Women's Day and in 2021, the theme is #GenerationEquality.
Equality is an important topic for us at IR Department. We work hard to be fair and equal across genders and races, in finding opportunities for our people and striving to win share of voice for our clients, who are often smaller fish, swimming in a sea of salmon and sharks.
On this #IWD2021, a few of our own brilliant women took a moment to share a quote an inspirational woman in their lives. We hope you enjoy the collection!
Christmas with IR Department

This year we've decided to reflect on the year but also look at the positive things that are coming up. Each of the team reflect on one thing they've learnt in 2020, what they are looking forward to the most over the Christmas period and the podcast or book that got them through the year!
We hope you enjoy, and Merry Christmas from the IR Department team!